ABVC BioPharma, Inc.
ABVC
$0.911
$0.0354.00%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 222.88% | 81.57% | 74.25% | -926.09% | 88.45% |
| Total Depreciation and Amortization | 2,461.43% | -47.37% | 923.08% | -99.64% | 4,692.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -301.27% | -28.74% | -85.00% | 4,382.32% | -96.37% |
| Change in Net Operating Assets | -1,850.79% | 102.57% | -269.20% | 160.67% | -26,616.67% |
| Cash from Operations | -387.48% | 116.93% | -114.31% | -9.92% | 68.32% |
| Capital Expenditure | -- | -- | -- | -- | 100.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | 393.16% |
| Cash from Investing | -- | -- | -- | -- | 308.94% |
| Total Debt Issued | -- | -- | -100.00% | 156.22% | 106.04% |
| Total Debt Repaid | 1.17% | -- | -- | -- | -- |
| Issuance of Common Stock | 126.41% | -96.12% | -- | -- | -100.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -100.00% | 243.29% | -95.27% |
| Cash from Financing | 499.93% | -116.74% | 28.44% | 1,660.94% | -97.68% |
| Foreign Exchange rate Adjustments | 662.50% | -99.65% | 187.92% | -56.83% | -207.36% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 246.49% | -67.66% | 244.98% | 85.70% | -206.73% |